Next Move Strategy Consulting.png
Global Biopharmaceutical Market to Generate USD 974.48 Billion by 2030, Outlines a New Report by Next Move Strategy Consulting
August 02, 2022 06:41 ET | Next Move Strategy Consulting
New York, Aug. 02, 2022 (GLOBE NEWSWIRE) -- According to the report published by Next Move Strategy Consulting, the global biopharmaceutical market generated USD 345.84 billion in 2021, and is...
Alvotech Initiates Patient Study for AVT06, a Proposed Biosimilar for Eylea®
July 07, 2022 08:35 ET | Alvotech
AVT06 is the third biosimilar candidate developed by Alvotech to enter clinical studies Eylea® (aflibercept) is used for the treatment of eye disorders and reached global sales of nearly US$10...
Alvotech Debuts on NASDAQ First North Growth Market Becoming First Dual-Listed Icelandic Company in United States and Iceland
June 22, 2022 18:56 ET | Alvotech
After the largest debut by an Icelandic company on a U.S. stock exchange, Alvotech is set to list its shares under the ticker symbol “ALVO” on the Nasdaq First North Growth Market in Iceland...
Supplement to the Company Description
June 22, 2022 18:25 ET | Alvotech
In connection to the filling on Form 20-F with the U.S. Securities and Exchange Commission (SEC),  Alvotech has published a supplement dated 22 June 2022 to the Company Description, dated 21 June...
Viðauki við Skráningarskjal
June 22, 2022 18:25 ET | Alvotech
Í tengslum við birtingu á formi 20-F hjá bandaríska verðbréfaeftirlitinu (SEC) þá hefur Alvotech birt viðauka dagsettan 22. júní 2022 við skráningarskjal félagsins dagsett 21. júní 2022. Við birtingu...
Avid Logo June 2022.jpg
Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2022 After Market Close on June 29, 2022
June 22, 2022 16:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., June 22, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices Announces Further Expansion of Process Development Capacity for Mammalian Cell Business
June 13, 2022 08:05 ET | Avid Bioservices, Inc
New Laboratories Have Potential to Support an Additional $20 Million in Annual Process Development Revenue, Doubling Current Mammalian Cell Process Development Capacity Expansion to Cost...
Aesthetic Management Partners
Aesthetic Management Partners Announces Exclusive Distribution Agreement With Estar Medical
May 23, 2022 08:00 ET | Aesthetic Management Partners
CORDOVA, Tenn., May 23, 2022 (GLOBE NEWSWIRE) -- Estar Medical, the maker of Eclipse PRP® and Tropocells®, has signed an exclusive long-term marketing and distribution agreement with Aesthetic...
Medi Tech Insights Logo.jpg
Global Bioprocess Containers Market valued at $3 Billion is set to witness an exponential growth of 27% in the upcoming 5 years
May 11, 2022 09:15 ET | Medi-Tech Insights
BRUSSELS, BELGIUM, May 11, 2022 (GLOBE NEWSWIRE) -- Description: Bioprocess Containers (BPCs) are ready-to-use single-use flexible container systems for important liquid handling applications...
AGC Biologics, CDMO, Contract Manufacturing Organization, Biologics Contract Development partners with Allergy Therapeutics on peanut vaccine manufacturing
Allergy Therapeutics Selects AGC Biologics to Manufacture Novel Peanut Allergy Vaccine Candidate
March 31, 2022 09:00 ET | AGC Biologics
Seattle, March 31, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new partnership with...